Beeftopia writes: The New York Genome Center and IBM will investigate whether Watson can be used to parse cancer genome data and then recommend treatments. The trial involves 20 to 25 glioblastoma patients with poor prognoses. The article states, "It should theoretically be possible to analyze [genomic] data and use it to customize a treatment that targets the specific mutations present in tumor cells. But right now, doing so requires a squad of highly trained geneticists, genomics experts, and clinicians. It's a situation that can't scale to handle the [number of] patients with glioblastoma, much less other cancers. Instead, that gusher of information is going to be pointed at Watson... Watson will figure out which mutations are distinct to the tumor, what protein networks they effect, and which drugs target proteins that are part of those networks. The net result will be a picture of the biochemical landscape inside the tumor cells, along with some suggestions on how clinicians might consider intervening to change the landscape.